Biosite Aims For 2004 Approval Of Triage For Ischemic, Hemorrhagic Stroke
This article was originally published in The Gray Sheet
Executive Summary
Biosite expects its Triage Stroke protein test to be adjunctive to computed tomography in diagnosing ischemic and hemorrhagic stroke in hospital and physician lab settings
You may also be interested in...
Beckman Agreement Will Give Biosite Automated Platform For BNP Assay
Biosite will leverage Beckman Coulter's U.S. installed base of automated immunoassay analyzers to grow its market share in BNP testing under a long-term development deal between the firms
Beckman Agreement Will Give Biosite Automated Platform For BNP Assay
Biosite will leverage Beckman Coulter's U.S. installed base of automated immunoassay analyzers to grow its market share in BNP testing under a long-term development deal between the firms
Biosite Triage Cardio ProfilER
Full-scale launch begins for chest pain diagnostic, offering quantitative creatinine kinase, myoglobin, troponin I and b-type natriuretic peptide measurements within 15 minutes. Cleared by FDA in March, the cardiovascular disease marker test addresses a $300 mil. potential market (1"The Gray Sheet" April 21, 2003, p. 42)...